These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 16488391)
21. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Sridhar SC; Miranti CK Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263 [TBL] [Abstract][Full Text] [Related]
22. [Function of IL-18 in promoting metastasis of lung cancer]. Jiang DF; Liu WL; Lu YL; Qiu ZY; He FC Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):348-52. PubMed ID: 12921563 [TBL] [Abstract][Full Text] [Related]
23. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Zhou B; Liu L; Reddivari M; Zhang XA Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270 [TBL] [Abstract][Full Text] [Related]
24. TIMP1 and adverse prognosis in non-small cell lung cancer. Fong KM; Kida Y; Zimmerman PV; Smith PJ Clin Cancer Res; 1996 Aug; 2(8):1369-72. PubMed ID: 9816309 [TBL] [Abstract][Full Text] [Related]
25. Elevated cell migration, invasion and tumorigenicity in human KB carcinoma cells transfected with COX-2 cDNA. Takaoka K; Kishimoto H; Segawa E; Hashitani S; Zushi Y; Noguchi K; Sakurai K; Urade M Int J Oncol; 2006 Nov; 29(5):1095-101. PubMed ID: 17016639 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. Ramer R; Hinz B J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069 [TBL] [Abstract][Full Text] [Related]
27. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1. Zeng TD; Zheng B; Zheng W; Chen C Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774 [TBL] [Abstract][Full Text] [Related]
28. Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells. Ramer R; Eichele K; Hinz B Oncogene; 2007 Aug; 26(39):5822-7. PubMed ID: 17369856 [TBL] [Abstract][Full Text] [Related]
29. [Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian cancer cells]. Hu XX; Li L; Li DR; Zhang W; Tang BJ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):662-5. PubMed ID: 17274370 [TBL] [Abstract][Full Text] [Related]
30. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Yu W; Liu J; Xiong X; Ai Y; Wang H Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433 [TBL] [Abstract][Full Text] [Related]
31. Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts. Taves J; Rastedt D; Canine J; Mork D; Wallert MA; Provost JJ Arch Biochem Biophys; 2008 Sep; 477(1):60-6. PubMed ID: 18539131 [TBL] [Abstract][Full Text] [Related]
32. The DSCs-expressed CD82 controls the invasiveness of trophoblast cells via integrinbeta1/MAPK/MAPK3/1 signaling pathway in human first-trimester pregnancy. Li MQ; Hou XF; Shao J; Tang CL; Li DJ Biol Reprod; 2010 May; 82(5):968-79. PubMed ID: 20075392 [TBL] [Abstract][Full Text] [Related]
33. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells. Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293 [TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effect of anti-type IV collagenase intrabody on invasiveness of human pulmonary giant cell carcinoma PG cells in vitro]. Shen EY; Wang WG; Zhang SH; Zhen YS Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):265-70. PubMed ID: 16875624 [TBL] [Abstract][Full Text] [Related]
35. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo. Zhang J; Wang B Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393 [TBL] [Abstract][Full Text] [Related]
36. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2. Zhang A; Meng L; Wang Q; Xi L; Chen G; Wang S; Zhou J; Lu Y; Ma D Oncol Rep; 2006 Apr; 15(4):831-6. PubMed ID: 16525667 [TBL] [Abstract][Full Text] [Related]
37. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer. Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249 [TBL] [Abstract][Full Text] [Related]
38. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549). Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363 [TBL] [Abstract][Full Text] [Related]
39. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. Huang CS; Fan YE; Lin CY; Hu ML J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831 [TBL] [Abstract][Full Text] [Related]
40. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Tang CH; Tan TW; Fu WM; Yang RS Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]